Pneumonia Research Today is a free monthly online journal that collates and summarizes the latest research about Pneumonia, including details on symptoms, viral, bacterial, treatment, causes, walking pneumonia.

Volume 1 (2004), Issue 2 (November)

1. Rhodococcus equi pneumonia in a renal transplant patient: a case report and review of literature.
   Clin Transplant, 18(6): 748-52. [Abstract] [Full-text]
2. Effectiveness of a publicly funded pneumococcal vaccination program against invasive pneumococcal disease among the elderly in Victoria, Australia.
   Vaccine, 23(2): 132-8. [Abstract] [Full-text]
3. Risk assessment of transmission of capsule-deficient, recombinant Actinobacillus pleuropneumoniae.
   Vet Microbiol, 104(1): 63-71. [Abstract] [Full-text]
4. Effectiveness of the MF59-adjuvanted influenza vaccine in preventing emergency admissions for pneumonia in the elderly over 64 years of age.
   Vaccine, 23(3): 283-9. [Abstract] [Full-text]
5. Vaccinations in pneumonia (VIP): pneumococcal and influenza vaccination patterns among patients hospitalized for pneumonia.
   Prev Med, 40(4): 384-8. [Abstract] [Full-text]
6. Lipopolysaccharide-induced pulmonary inflammation is not accompanied by a release of anandamide into the lavage fluid or a down-regulation of the activity of fatty acid amide hydrolase.
   Life Sci, 76(4): 461-72. [Abstract] [Full-text]
7. Surfactant function in children with chronic airway inflammation.
   J Appl Physiol, 97(6): 2160-5. [Abstract] [Full-text]
8. T-cell-mediated inflammation does not contribute to the maintenance of airway dysfunction in mice.
   J Appl Physiol, 97(6): 2258-65. [Abstract] [Full-text]
9. The role of glottal gap in predicting aspiration in patients with unilateral vocal paralysis.
   Clin Otolaryngol Allied Sci, 29(6): 709-12. [Abstract] [Full-text]
10. Characterization of antibodies to PspA and PsaA in adults over 50 years of age with invasive pneumococcal disease.
    Vaccine, 23(6): 789-93. [Abstract] [Full-text]
11. Inflammatory cells as source of tachykinin-induced mucus secretion in chronic bronchitis.
    Regul Pept, 124(1): 195-201. [Abstract] [Full-text]
12. Oral vaccination of BALB/c mice with Salmonella enterica serovar Typhimurium expressing Pseudomonas aeruginosa O antigen promotes increased survival in an acute fatal pneumonia model.
    Infect Immun, 72(12): 7012-21. [Abstract] [Full-text]
13. Pulmonary and systemic bacterial co-infections in severe RSV bronchiolitis.
    Arch Dis Child, 89(12): 1155-7. [Abstract] [Full-text]
14. Antimicrobial therapy of community-acquired pneumonia.
    Infect Dis Clin North Am, 18(4): 993-1016, xi. [Abstract] [Full-text]
15. Local guidelines for community-acquired pneumonia: development, implementation, and outcome studies.
    Infect Dis Clin North Am, 18(4): 975-91. [Abstract] [Full-text]
16. Re-evaluation of the therapy of severe pneumonia caused by Streptococcus pneumoniae.
    Infect Dis Clin North Am, 18(4): 963-74; x-xi. [Abstract] [Full-text]
17. Healthcare-associated pneumonia in adults: management principles to improve outcomes.
    Infect Dis Clin North Am, 18(4): 939-62. [Abstract] [Full-text]
18. Nonresponses and treatment failures with conventional empiric regimens in patients with community-acquired pneumonia.
    Infect Dis Clin North Am, 18(4): 883-97. [Abstract] [Full-text]
19. Processes of care for community-acquired pneumonia.
    Infect Dis Clin North Am, 18(4): 843-59. [Abstract] [Full-text]
20. Empiric treatment of ambulatory community-acquired pneumonia: always include treatment for atypical agents.
    Infect Dis Clin North Am, 18(4): 829-41. [Abstract] [Full-text]
21. Diagnostic test for etiologic agents of community-acquired pneumonia.
    Infect Dis Clin North Am, 18(4): 809-27. [Abstract] [Full-text]
22. Community-acquired pneumonia: severity of illness evaluation.
    Infect Dis Clin North Am, 18(4): 791-807; viii. [Abstract] [Full-text]
23. Antibacterial drug resistance: implications for the treatment of patients with community-acquired pneumonia.
    Infect Dis Clin North Am, 18(4): 777-90. [Abstract] [Full-text]
24. Epidemiology and etiology of community-acquired pneumonia.
    Infect Dis Clin North Am, 18(4): 761-76, vii. [Abstract] [Full-text]
25. Community-acquired pneumonia: pathophysiology and host factors with focus on possible new approaches to management of lower respiratory tract infections.
    Infect Dis Clin North Am, 18(4): 743-59, vii. [Abstract] [Full-text]
26. Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan.
    Antimicrob Agents Chemother, 48(12): 4624-30. [Abstract] [Full-text]
27. Pneumonitis following grease gun injury.
    Injury, 35(12): 1303-5. [Abstract] [Full-text]
28. Impact of cigarette smoke on clearance and inflammation after Pseudomonas aeruginosa infection.
    Am J Respir Crit Care Med, 170(11): 1164-71. [Abstract] [Full-text]
29. Blending of a conventional Mycoplasma hyopneumoniae vaccine with a positive marker: tracking of immunised pigs by peptide-specific antibodies raised to the marker component.
    Res Vet Sci, 78(2): 135-41. [Abstract] [Full-text]
30. Methemoglobinemia in children with acute lymphoblastic leukemia (ALL) receiving dapsone for pneumocystis carinii pneumonia (PCP) prophylaxis: a correlation with cytochrome b5 reductase (Cb5R) enzyme levels.
    Pediatr Blood Cancer, 44(1): 55-62. [Abstract] [Full-text]

© 2004-2008 Pneumonia Research Today. All Rights Reserved.